SQZ BIOTECHNOLOGIES CO (SQZ)
US78472W1045 - Common Stock
| TTM (2023-3-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -76.11M | -79.46M | -68.74M | -50.52M | -32.20M | |||
| Depreciation Amortization | 1.44M | 1.50M | 1.21M | 1.34M | 1.38M | |||
| Change In Working Capital | -29.90M | -24.20M | -32.94M | -7.28M | -6.83M | |||
| Other non cash items | 17.68M | 18.62M | 18.33M | 13.31M | 4.16M | |||
| OPERATING CASH FLOW | -86.89M | -83.55M | -82.14M | -43.15M | -33.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -359.00K | -522.00K | -613.00K | -1.18M | -2.17M | |||
| Other Investing Activity | 0.00 | 34.00K | 0.00 | 59.00M | -10.68M | |||
| INVESTING CASH FLOW | -359.00K | -488.00K | -613.00K | 57.82M | -12.85M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 4.20M | 4.23M | 1.41M | 118.18M | 26.04M | |||
| Other Financing Activity | N/A | 0.00 | 54.50M | -1.76M | 0.00 | |||
| FINANCING CASH FLOW | 4.20M | 4.23M | 55.91M | 116.42M | 26.04M | |||
| CHANGE IN CASH | -83.04M | -79.80M | -26.84M | 131.09M | -20.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -86.89M | -83.55M | -82.14M | -43.15M | -33.49M | |||
| Capital Expenditure | -359.00K | -522.00K | -613.00K | -1.18M | -2.17M | |||
| FREE CASH FLOW | -87.25M | -84.07M | -82.75M | -44.33M | -35.66M | |||
All data in USD